Top Suppliers:I want be here

1613-37-2

1613-37-2 structure
1613-37-2 structure

Name Quinoline-N-oxide hydrate
Synonyms glyphosate-potassium
1-oxidoquinolin-1-ium
EINECS 216-560-6
Quinoline 1-oxide
MFCD00006737
Quinoline N-Oxide Hydrate
Glycine, N-(phosphonomethyl)-, potassium salt (1:1)
Potassium [(phosphonomethyl)amino]acetate
Density 1.13g/cm3
Boiling Point 173 °C / 4mmHg
Melting Point 48-53 °C
Molecular Formula C3H7KNO5P
Molecular Weight 207.163
Flash Point 135.2ºC
Exact Mass 206.969894
PSA 25.46000
LogP 2.26830
Vapour Pressure 0.00206mmHg at 25°C
Index of Refraction 1.597
Name: Quinoline-n-oxide hydrate Material Safety Data Sheet
Synonym:
CAS: 1613-37-2
Section 1 - Chemical Product MSDS Name:Quinoline-n-oxide hydrate Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
1613-37-2 Quinoline-N-oxide hydrate 216-560-6
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.Hygroscopic (absorbs moisture from the air).
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
No information found.
Inhalation:
May cause respiratory tract irritation.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Get medical aid if irritation develops or persists.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. Get medical aid if cough or other symptoms appear.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower.
Exposure Limits CAS# 1613-37-2: Personal Protective Equipment Eyes: Wear chemical splash goggles.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear a chemical apron.
Respirators:
A NIOSH/MSHA approved air purifying dust or mist respirator or European Standard EN 149.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 52 - 55 deg C
Autoignition Temperature: Not available.
Flash Point: > 112 deg C (> 233.60 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C9H7NO.xH2O
Molecular Weight: 145.16

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Exposure to moist air or water.
Incompatibilities with Other Materials:
Strong oxidizing agents - moisture.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, carbon dioxide.
Hazardous Polymerization: Has not been reported.

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 1613-37-2: VC2340000 LD50/LC50:
Not available.
Carcinogenicity:
Quinoline-N-oxide hydrate - Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 1613-37-2: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 1613-37-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 1613-37-2 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

CHEMICAL IDENTIFICATION

RTECS NUMBER :
VC2340000
CHEMICAL NAME :
Quinoline, 1-oxide
CAS REGISTRY NUMBER :
1613-37-2
LAST UPDATED :
198906
DATA ITEMS CITED :
1
MOLECULAR FORMULA :
C9-H7-N-O
MOLECULAR WEIGHT :
145.17

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

MUTATION DATA

TYPE OF TEST :
Mutation test systems - not otherwise specified
TEST SYSTEM :
Bacteria - Escherichia coli
DOSE/DURATION :
50 umol/L
REFERENCE :
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 203,81,1988
Hazard Codes Xn
Safety Phrases S24/25
RTECS VC2335000
HS Code 2933499090

~97%

1613-37-2 structure

1613-37-2

Literature: Larionov, Oleg V.; Stephens, David; Mfuh, Adelphe M.; Arman, Hadi D.; Naumova, Anastasia S.; Chavez, Gabriel; Skenderi, Behije Organic and Biomolecular Chemistry, 2014 , vol. 12, # 19 p. 3026 - 3036

~88%

1613-37-2 structure

1613-37-2

Literature: Baik, Woonphil; Kim, Dong Ik; Lee, Hyun Joo; Chung, Wook-Jin; Kim, Byeong Hyo; Lee, Seok Woo Tetrahedron Letters, 1997 , vol. 38, # 26 p. 4579 - 4580

~73%

1613-37-2 structure

1613-37-2

Literature: Yousif, M. M.; Fadda, A. A.; Elmorsy, S. S.; Hassan, H. M. Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1987 , vol. 26, p. 994 - 997

~%

1613-37-2 structure

1613-37-2

Literature: Journal of the American Chemical Society, , vol. 66, p. 621,624 Chemische Berichte, , vol. 69, p. 1566

~%

1613-37-2 structure

1613-37-2

Literature: Chemical & Pharmaceutical Bulletin, , vol. 36, # 10 p. 3753 - 3759

~99%

1613-37-2 structure

1613-37-2

Literature: Liotta, R.; Hoff, W. S. Journal of Organic Chemistry, 1980 , vol. 45, # 14 p. 2887 - 2890

~%

1613-37-2 structure

1613-37-2

Literature: Chemistry of Heterocyclic Compounds (New York, NY, United States), , p. 203 - 206 Khimiya Geterotsiklicheskikh Soedinenii, , vol. 19, # 2 p. 249 - 251

~%

1613-37-2 structure

1613-37-2

Literature: Pharmazie, , vol. 38, # 12 p. 891 - 891

~%

1613-37-2 structure

1613-37-2

Literature: Chemische Berichte, , vol. 59, p. 1850 Chemische Berichte, , vol. 66, p. 986 Anm. 7
HS Code 2933499090
Summary 2933499090. other compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%